ADVANCED LEIOMYOSARCOMA
Clinical trials for ADVANCED LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for sarcoma patients: drug combo aims to shrink tumors
Disease control Recruiting nowThis study tests a new two-drug treatment for people with advanced soft tissue sarcomas (cancers of the muscles, fat, or other connective tissues). The drugs, abemaciclib and gemcitabine, work together to stop cancer cells from growing. The trial will compare this new combo to th…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy hopes to slow sarcoma growth
Disease control Recruiting nowThis early-phase trial tests whether adding zanzalintinib to the chemotherapy drug eribulin can help control advanced liposarcoma and leiomyosarcoma better than eribulin alone. About 18 adults whose cancer has worsened after prior treatments will receive the combination. The main…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC